Arkolith/Insider Trading/HCWB/Form 4

Byam Rebecca

Chief Financial OfficerHCW Biologics Inc. (HCWB) · full profile →Form 4 · filed Sep 1, 2022
Net Buying
Open-Market Buys
$44K
Open-Market Sells
$0
Net Open-Market Flow
$44K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 31, 2022Buy(P)10K$2.56$26K283K
Aug 30, 2022Buy(P)7K$2.55$18K273K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-048239) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML